Last reviewed · How we verify
Immediate Release Oxycodone
Immediate Release Oxycodone, marketed by the University of Rochester, holds a position in the pain management market with a key composition patent expiring in 2028. The drug's primary strength lies in its well-established mechanism for effective pain relief, supported by its current market presence. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | Immediate Release Oxycodone |
|---|---|
| Also known as | Medication comparison |
| Sponsor | University of Rochester |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain (PHASE1)
- A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy (PHASE3)
- Low-dose Buccal Buprenorphine: Relative Abuse Potential and Analgesia (PHASE4)
- Multimodal Analgesia Strategies After Major Shoulder Ambulatory Surgery (PHASE4)
- Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain (PHASE4)
- Rebound Pain Following Regional Anaesthesia for Ankle Fracture Surgery (PHASE4)
- Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints (EARLY_PHASE1)
- Is the Rate of Early Mobilisation in Hip Fracture Patients Using Alfentanil Better Than Standard Opioid Analgesia?
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Immediate Release Oxycodone CI brief — competitive landscape report
- Immediate Release Oxycodone updates RSS · CI watch RSS
- University of Rochester portfolio CI